Formulation and Evaluation on Synergetic Anti-Hepatoma Effect of a Chemically Stable and Release-Controlled Nanoself-Assembly with Natural Monomers

References

• Wang S, Huang Y, Hu W, et al. Detachable string magnetically controlled capsule endoscopy for detecting high-risk varices in compensated advanced chronic liver disease (CHESS1801): a prospective multicenter study. Lancet Region Health. 2021;6:100072. doi:10.1016/j.lanwpc.2020.100072
   Google Scholar
• Yang R, Wang LQ, Yuan BC, Liu Y. The pharmacological activities of licorice. Planta Med. 2015;81:1654–1669. doi:10.1055/s-0035-1557893
   PubMed Web of Science ®Google Scholar
• Li Z, Zou J, Cao D, Ma X. Pharmacological basis of tanshinone and new insights into tanshinone as a multitarget natural product for multifaceted diseases. Biomed Pharmacother. 2020;130:110599. doi:10.1016/j.biopha.2020.110599
   PubMed Web of Science ®Google Scholar
• Subedi L, Gaire BP. Tanshinone IIA: a phytochemical as a promising drug candidate for neurodegenerative diseases. Pharmacol Res. 2021;169:105661. doi:10.1016/j.phrs.2021.105661
   PubMed Web of Science ®Google Scholar
• Wang ZY, Nixon DW. Licorice and cancer. Nutr Cancer. 2001;39:1–11. doi:10.1207/S15327914nc391_1
   PubMed Web of Science ®Google Scholar
• Wang D, Yu W, Cao L, et al. Comparative pharmacokinetics and tissue distribution of cryptotanshinone, tanshinone IIA, dihydrotanshinone I, and tanshinone I after oral administration of pure tanshinones and liposoluble extract of Salvia miltiorrhiza to rats. Biopharm Drug Dispos. 2020;41:54–63. doi:10.1002/bdd.2213
   PubMed Web of Science ®Google Scholar
• Shen C, Zhu J, Song J, Shen B, Yuan H, Li X. Formulation of pluronic F127/TPGS mixed micelles to improve the oral absorption of glycyrrhizic acid. Drug Dev Ind Pharm. 2020;46:1100–1107. doi:10.1080/03639045.2020.1775634
   PubMed Web of Science ®Google Scholar
• Nazari S, Rameshrad M, Hosseinzadeh H. Toxicological effects of Glycyrrhiza glabra (licorice). Phytother Res. 2017;31:1635–1650. doi:10.1002/ptr.5893
   PubMed Web of Science ®Google Scholar
• Ashour AA, El-Kamel AH, Abdelmonsif DA, Khalifa HM, Ramadan AA. Modified lipid nanocapsules for targeted tanshinone IIA delivery in liver fibrosis. Int J Nanomed. 2021;16:8013–8033. doi:10.2147/IJN.S331690
   PubMedGoogle Scholar
• Li H, Hu P, Zou Y, et al. Tanshinone IIA and hepatocellular carcinoma: a potential therapeutic drug. Front Oncol. 2023;13:1071415. doi:10.3389/fonc.2023.1071415
   PubMed Web of Science ®Google Scholar
• Liu YW, Huang YT. Inhibitory effect of tanshinone IIA on rat hepatic stellate cells. PLoS One. 2014;9:e103229. doi:10.1371/journal.pone.0103229
   PubMed Web of Science ®Google Scholar
• Sun X, Tan Y, Lyu J, Liu HL, Zhao ZM, Liu CH. Active components formulation developed from Fuzheng Huayu recipe for anti-liver fibrosis. Chin J Integr Med. 2022;28:538–544. doi:10.1007/s11655-021-3293-x
   PubMed Web of Science ®Google Scholar
• Tang ZH, Li T, Chang LL, et al. Glycyrrhetinic acid triggers a protective autophagy by activation of extracellular regulated protein kinases in hepatocellular carcinoma cells. J Agric Food Chem. 2014;62:11910–11916. doi:10.1021/jf503968k
   PubMed Web of Science ®Google Scholar
• Wang X-F, Zhou Q-M, Lu -Y-Y, Zhang H, Huang S, Su B. Glycyrrhetinic acid potently suppresses breast cancer invasion and metastasis by impairing the p38 MAPK-AP1 signaling axis. Expert Opin Ther Targets. 2015;19:577–587. doi:10.1517/14728222.2015.1012156
   PubMed Web of Science ®Google Scholar
• Huang RY, Chu YL, Huang QC, Chen XM, Jiang ZB, Zhang X. 18beta-glycyrrhetinic acid suppresses cell proliferation through inhibiting thromboxane synthase in non-small cell lung cancer. PLoS One. 2014;9:e93690. doi:10.1371/journal.pone.0093690
   PubMed Web of Science ®Google Scholar
• Wang S, Shen Y, Qiu R, Chen W, Chen W, Chen W. 18 beta-glycyrrhetinic acid exhibits potent antitumor effects against colorectal cancer via inhibition of cell proliferation and migration. Int J Oncol. 2017;51:615–624. doi:10.3892/ijo.2017.4059
   PubMed Web of Science ®Google Scholar
• Wang W, Lei Y, Sui H, et al. Fabrication and evaluation of nanoparticle-assembled BSA microparticles for enhanced liver delivery of glycyrrhetinic acid. Artif Cells Nanomed Biotechnol. 2017;45:740–747. doi:10.1080/21691401.2016.1193024
   PubMed Web of Science ®Google Scholar
• Wolfram RK, Heller L, Csuk R. Targeting mitochondria: esters of rhodamine B with triterpenoids are mitocanic triggers of apoptosis. Eur J Med Chem. 2018;152:21–30. doi:10.1016/j.ejmech.2018.04.031
   PubMed Web of Science ®Google Scholar
• Sun G, Sun J, Sun J. Combination prostate cancer therapy: prostate-specific membranes antigen targeted, pH-sensitive nanoparticles loaded with doxorubicin and tanshinone. Drug Deliv. 2021;28:1132–1140. doi:10.1080/10717544.2021.1931559
   PubMed Web of Science ®Google Scholar
• Chu T, Zhang Q, Li H, et al. Development of intravenous lipid emulsion of tanshinone IIA and evaluation of its anti-hepatoma activity in vitro. Int J Pharm. 2012;424:76–88. doi:10.1016/j.ijpharm.2011.12.049
   PubMedGoogle Scholar
• Chen F, Zhang J, He Y, Fang X, Wang Y, Chen M. Glycyrrhetinic acid-decorated and reduction-sensitive micelles to enhance the bioavailability and anti-hepatocellular carcinoma efficacy of tanshinone IIA. Biomater Sci. 2016;4:167–182. doi:10.1039/C5BM00224A
   PubMed Web of Science ®Google Scholar
• Zong L, Wang H, Hou X, et al. A novel GSH-triggered polymeric nanomicelles for reversing MDR and enhancing antitumor efficiency of hydroxycamptothecin. Int J Pharm. 2021;600:120528. doi:10.1016/j.ijpharm.2021.120528
   PubMed Web of Science ®Google Scholar
• Pártay LB, Sega M, Jedlovszky P. Morphology of bile salt micelles as studied by computer simulation methods. Langmuir. 2007;23:12322–12328. doi:10.1021/la701749u
   PubMed Web of Science ®Google Scholar
• Zeng M, Xue Y, Zeng M-H, Zeng M-H, Zeng M-H, Zeng M-H. CuBr-promoted domino Biginelli reaction for the diastereoselective synthesis of bridged polyheterocycles: mechanism studies and in vitro anti-tumor activities. Chin Chem Lett. 2022;33:4891–4895. doi:10.1016/j.cclet.2022.02.075
   Web of Science ®Google Scholar
• Wu H, Huang C, Wang L, et al. Folate-targeted co-delivery polymersomes for efficient photo-chemo-antiangiogenic therapy against breast cancer and in vivo evaluation via OCTA/NIRF dual-modal imaging. Chin Chem Lett. 2022;33:5035–5041. doi:10.1016/j.cclet.2022.04.021
   Web of Science ®Google Scholar
• Zheng P, Liu Y, Chen J, Xu W, Li G, Ding J. Targeted pH-responsive polyion complex micelle for controlled intracellular drug delivery. Chin Chem Lett. 2020;31:1178–1182. doi:10.1016/j.cclet.2019.12.001
   Web of Science ®Google Scholar
• Jin R, Liu Z, Liu T, Yuan P, Bai Y, Chen X. Redox-responsive micelles integrating catalytic nanomedicine and selective chemotherapy for effective tumor treatment. Chin Chem Lett. 2021;32:3076–3082. doi:10.1016/j.cclet.2021.03.084
   Web of Science ®Google Scholar
• Qiao Y, Wei Z, Qin T, et al. Combined nanosuspensions from two natural active ingredients for cancer therapy with reduced side effects. Chin Chem Lett. 2021;32:2877–2881. doi:10.1016/j.cclet.2021.03.049
   Web of Science ®Google Scholar
• He M, Yu L, Yang Y, et al. Delivery of triptolide with reduction-sensitive polymer nanoparticles for liver cancer therapy on patient-derived xenografts models. Chin Chem Lett. 2020;31:3178–3182. doi:10.1016/j.cclet.2020.05.034
   Web of Science ®Google Scholar
• Wang Y, Wang X, Zhang J, et al. Gambogic acid-encapsulated polymeric micelles improved therapeutic effects on pancreatic cancer. Chin Chem Lett. 2019;30:885–888. doi:10.1016/j.cclet.2019.02.018
   Web of Science ®Google Scholar
• Bitencourt-Ferreira G, Pintro VO, de Azevedo X. Docking with AutoDock4. Methods Mol Biol. 2019;2019:125–148.
   Google Scholar
• Pu X, Zhao L, Li J, et al. A polymeric micelle with an endosomal pH-sensitivity for intracellular delivery and enhanced antitumor efficacy of hydroxycamptothecin. Acta Biomater. 2019;88:357–369. doi:10.1016/j.actbio.2019.02.039
   PubMed Web of Science ®Google Scholar
• Cao H, Ma R, Chu S, Xi J, Yu L, Guo R. Synergistic effect of T80/B30 vesicles and T80/PN320 mixed micelles with Se/C on nasal mucosal immunity. Chin Chem Lett. 2021;32:2761–2764. doi:10.1016/j.cclet.2021.03.029
   Web of Science ®Google Scholar
• Pu X, Zhou X, Huang Z, Yin G, Chen X. Fabrication of extracellular matrix-coated conductive polypyrrole-poly(l-lactide) fiber-films and their synergistic effect with (nerve growth factor)/(epidermal growth factor) on neurites growth. Chin Chem Lett. 2020;31:1141–1146. doi:10.1016/j.cclet.2019.07.002
   Web of Science ®Google Scholar
• Yunchu Z, Tingting L, Yihong H, Jing C, Xiang G, Yan Z. Co-delivery of doxorubicin and curcumin via cRGD-peptide modified PEG-PLA self-assembly nanomicelles for lung cancer therapy. Chin Chem Lett. 2022;33:2507–2511. doi:10.1016/j.cclet.2021.11.076
   Web of Science ®Google Scholar
• Lan M, Chunlai N, Rangrang F, et al. Facile construction of targeted pH-responsive DNA-conjugated gold nanoparticles for synergistic photothermal-chemotherapy. Chin Chem Lett. 2021;32:1775–1779. doi:10.1016/j.cclet.2020.12.058
   Web of Science ®Google Scholar
• Shan L, Chao J, Peng H, et al. Mild hyperthermia-enhanced chemo-photothermal synergistic therapy using doxorubicin-loaded gold nanovesicles. Chin Chem Lett. 2021;32:2411–2414. doi:10.1016/j.cclet.2021.03.080
   Web of Science ®Google Scholar
• Chenyu G, Jun W, Bo L, et al. Bioactive gelatin cryogels with BMP-2 biomimetic peptide and VEGF: a potential scaffold for synergistically induced osteogenesis. Chin Chem Lett. 2022;33:1956–1962. doi:10.1016/j.cclet.2021.10.070
   Web of Science ®Google Scholar
• Bengang X, Shuang L, Fan J, et al. Tumor microenvironment-responsive MnSiO3-Pt@BSA-Ce6 nanoplatform for synergistic catalysis-enhanced sonodynamic and chemodynamic cancer therapy. Chin Chem Lett. 2022;33:2959–2964. doi:10.1016/j.cclet.2021.12.096
   Web of Science ®Google Scholar
• Ma L, Jiang H, Xu X, et al. Tanshinone IIA mediates SMAD7-YAP interaction to inhibit liver cancer growth by inactivating the transforming growth factor beta signaling pathway. Aging. 2019;11:9719–9737. doi:10.18632/aging.102420
   PubMedGoogle Scholar
• Cai H, Chen X, Zhang J, Wang J. 18beta-glycyrrhetinic acid inhibits migration and invasion of human gastric cancer cells via the ROS/PKC-alpha/ERK pathway. J Nat Med. 2018;72:252–259. doi:10.1007/s11418-017-1145-y
   PubMed Web of Science ®Google Scholar
• Yuan L, Yang Y, Li X, et al. 18beta-glycyrrhetinic acid regulates mitochondrial ribosomal protein L35-associated apoptosis signaling pathways to inhibit proliferation of gastric carcinoma cells. World J Gastroenterol. 2022;28:2437–2456. doi:10.3748/wjg.v28.i22.2437
   PubMed Web of Science ®Google Scholar
• Irshad R, Raj N, Gabr GA, Manzoor N, Husain M. Integrated network pharmacology and experimental analysis unveil multi-targeted effect of 18alpha- glycyrrhetinic acid against non-small cell lung cancer. Front Pharmacol. 2022;13:1018974. doi:10.3389/fphar.2022.1018974
   PubMedGoogle Scholar
• Du J, Zong L, Li M, et al. Two-pronged anti-tumor therapy by a new polymer-paclitaxel conjugate micelle with an anti-multidrug resistance effect. Int J Nanomed. 2022;17:1323–1341. doi:10.2147/IJN.S348598
   PubMed Web of Science ®Google Scholar
• Kojo Y, Matsunaga S, Suzuki H, Onoue S, Onoue S, Onoue S. Improved oral absorption profile of itraconazole in hypochlorhydria by self-micellizing solid dispersion approach. Eur J Pharm Sci. 2017;97:55–61. doi:10.1016/j.ejps.2016.10.032
   PubMed Web of Science ®Google Scholar
• Zong L, Li X, Wang H, et al. Formulation and characterization of biocompatible and stable I.V. itraconazole nanosuspensions stabilized by a new stabilizer polyethylene glycol-poly(beta-Benzyl-l-aspartate) (PEG-PBLA). Int J Pharm. 2017;531:108–117. doi:10.1016/j.ijpharm.2017.08.082
   PubMed Web of Science ®Google Scholar
• Liu MC, Liu B, Sun XY, et al. Core/shell structured Fe(3)O(4)@TiO(2)-DNM nanospheres as multifunctional anticancer platform: chemotherapy and photodynamic therapy research. J Nanosci Nanotechnol. 2018;18:4445–4456. doi:10.1166/jnn.2018.15338
   PubMed Web of Science ®Google Scholar
• Yang X, Cai X, Yu A, Xi Y, Zhai G. Redox-sensitive self-assembled nanoparticles based on alpha-tocopherol succinate-modified heparin for intracellular delivery of paclitaxel. J Colloid Interface Sci. 2017;496:311–326. doi:10.1016/j.jcis.2017.02.033
   PubMed Web of Science ®Google Scholar
• Wang H, Zhao Y, Wu Y, Nan K, Nie G, Chen H. Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles. Biomaterials. 2011;32:8281–8290. doi:10.1016/j.biomaterials.2011.07.032
   PubMed Web of Science ®Google Scholar
• Fu X, Zhang G, Zhang Y, Sun H, Yang S, Cui J. Co-delivery of anticancer drugs and cell penetrating peptides for improved cancer therapy. Chin Chem Lett. 2021;32:1559–1562. doi:10.1016/j.cclet.2020.10.011
   Web of Science ®Google Scholar
• Cao M, Zuo J, Yang G, et al. Physiology-based pharmacokinetic study on 18β-glycyrrhetic acid mono-glucuronide (GAMG) prior to glycyrrhizin in rats. Molecules. 2022;27:4657. doi:10.3390/molecules27144657
   PubMed Web of Science ®Google Scholar
• Lu JZ, Hong DD, Ye D, et al. Tissue distribution and integrated pharmacokinetic properties of major effective constituents of oral Gegen-Qinlian decoction in mice. Front Pharmacol. 2022;13. doi:10.3389/fphar.2022.996143
   Web of Science ®Google Scholar
• Sahu BP, Hazarika H, Bharadwaj R, et al. Curcumin-docetaxel co-loaded nanosuspension for enhanced anti-breast cancer activity. Expert Opin Drug Deliv. 2016;13:1065–1074. doi:10.1080/17425247.2016.1182486
   PubMed Web of Science ®Google Scholar
• Chi Y, Yin X, Sun K, et al. Redox-sensitive and hyaluronic acid functionalized liposomes for cytoplasmic drug delivery to osteosarcoma in animal models. J Control Release. 2017;261:113–125. doi:10.1016/j.jconrel.2017.06.027
   PubMed Web of Science ®Google Scholar
• Chen YC, Liao LC, Lu PL, et al. The accumulation of dual pH and temperature responsive micelles in tumors. Biomaterials. 2012;33:4576–4588. doi:10.1016/j.biomaterials.2012.02.059
   PubMed Web of Science ®Google Scholar
• Parveen S, Sahoo SK. Long circulating chitosan/PEG blended PLGA nanoparticle for tumor drug delivery. Eur J Pharmacol. 2011;670:372–383. doi:10.1016/j.ejphar.2011.09.023
   PubMed Web of Science ®Google Scholar
• Yin S, Li J, Gu X, Gu X, Gu X. Preparation and characterization of long-circulating PELMD/mPEG–PLGA-mixed micelles for 10-hydroxycamptothecin. J Nanoparticle Res. 2014;16:1–14. doi:10.1007/s11051-014-2274-9
   Web of Science ®Google Scholar
• Mishra P, Nayak B, Dey RK. PEGylation in anti-cancer therapy: an overview. Asian J Pharma Sci. 2016;11:337–348. doi:10.1016/j.ajps.2015.08.011
   Web of Science ®Google Scholar
• Pu XH, Sun J, Qin YM, et al. The passive targeting and the cytotoxicity of intravenous 10-HCPT nanosuspension. Curr Nanosci. 2012;8:762–766. doi:10.2174/157341312802884553
   Web of Science ®Google Scholar
• Zhou L, Du C, Zhang R, Dong C. Stimuli-responsive dual drugs-conjugated polydopamine nanoparticles for the combination photothermal-cocktail chemotherapy. Chin Chem Lett. 2021;32:561–564. doi:10.1016/j.cclet.2020.02.043
   Web of Science ®Google Scholar
• Wang Q, Gao Z, Zhao K, et al. Co-delivery of enzymes and photosensitizers via metal-phenolic network capsules for enhanced photodynamic therapy. Chin Chem Lett. 2022;33:1917–1922. doi:10.1016/j.cclet.2021.11.040
   Web of Science ®Google Scholar
• Yang L, Jiang J, Hong J, Liao Y, Kuang H, Wang X. High drug payload 10-hydroxycamptothecin nanosuspensions stabilized by cholesterol-PEG: in vitro and in vivo investigation. J Biomed Nanotechnol. 2015;11:711–721. doi:10.1166/jbn.2015.2050
   PubMed Web of Science ®Google Scholar